EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
about
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and DementiaA fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's diseaseClinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.A Surgical Method to Improve the Homeostasis of CSF for the Treatment of Alzheimer's Disease.Dementia: What pharmacists need to know.Memantine ER/Donepezil: A Review in Alzheimer's Disease.Benefits and risks of add-on therapies for Alzheimer's disease.Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.The Black Book of Psychotropic Dosing and Monitoring.Alzheimer disease. Donepezil and nursing home placement--benefits and costs.[Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia].Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study.Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease.
P2860
Q28067460-FCAE9AD0-F2BA-4FC0-AD98-AB02E3926165Q28076715-B033A2D2-9420-4FDB-9C0F-FC3B6113DD3BQ31155412-579B7F72-11F7-4209-B4EF-3582919A0A30Q37385649-0974F5FE-A436-4953-9EAA-24C1647768FBQ37741796-72D6869A-5522-4A03-8D3A-6328DE36C1C7Q38401091-F3FA34C1-9D44-4E36-815E-83AEAE3C4205Q38620338-61E4B0EA-82E6-4419-B193-C1798AC8EF54Q38839191-D3828BCD-C52F-4D96-B0B1-0F7A6129084EQ38906350-932ECD40-B07B-4B0C-8794-5FB7DC4836CEQ40239798-FEE0FE49-EF5D-42C7-ACEC-A73AE964C402Q47642128-DE1981F4-B24F-46BC-AC04-6816B28AA306Q53371557-96EF4ABD-3CAC-4997-A0C0-C7A227D14623Q53497639-F76F1E75-8DF5-498D-BC24-63E469882F00Q55093805-F8979829-FFF5-4918-819F-4DFDA85FF280Q55545970-E5EDE258-C835-452B-92C2-665F7861B04B
P2860
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
EFNS-ENS/EAN Guideline on conc ...... to severe Alzheimer's disease.
@en
type
label
EFNS-ENS/EAN Guideline on conc ...... to severe Alzheimer's disease.
@en
prefLabel
EFNS-ENS/EAN Guideline on conc ...... to severe Alzheimer's disease.
@en
P2093
P2860
P50
P356
P1476
EFNS-ENS/EAN Guideline on conc ...... to severe Alzheimer's disease.
@en
P2093
F H Bouwman
M T Heneka
P Scheltens
P2860
P304
P356
10.1111/ENE.12707
P50
P577
2015-03-25T00:00:00Z